Soru

Zorluk: OrtaMonitoring and Treatment Evaluation

A 6868-year-old man is evaluated on hospital day 33 for acute decompensated heart failure. On admission, he had severe dyspnea, orthopnea, and 3+3+ bilateral lower extremity edema. He was initiated on intravenous bumetanide. Over the past 4848 hours, his total urine output has been 6,500 mL6,500\text{ mL}, and his weight has decreased from 92 kg92\text{ kg} to 86 kg86\text{ kg}. Today, the patient reports significant improvement in his breathing and is able to lie flat comfortably. Physical examination shows clear lungs bilaterally and trace lower extremity edema. Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 112/70 mmHg112/70\text{ mmHg}, and heart rate 82/min82/\text{min}.

Laboratory studies today:
Blood urea nitrogen: 54 mg/dL54\text{ mg/dL} (baseline 24 mg/dL24\text{ mg/dL})
Serum creatinine: 2.3 mg/dL2.3\text{ mg/dL} (baseline 1.2 mg/dL1.2\text{ mg/dL})

Which of the following is the most appropriate next step in management?

  1. A
    Administer an intravenous bolus of 0.9%0.9\% sodium chloride
  2. B
    Continue intravenous bumetanide at the current dose
  3. Hold intravenous bumetanide and monitor renal functionCevap
  4. D
    Add oral metolazone
  5. E
    Obtain a renal ultrasound

Cevap

The correct answer is to hold intravenous bumetanide and monitor renal function.
The patient has experienced significant diuresis, evidenced by a 6 kg6\text{ kg} weight loss, 6,500 mL6,500\text{ mL} urine output, and resolution of his heart failure symptoms. However, his new laboratory findings show an acute rise in blood urea nitrogen and serum creatinine, with a BUN-to-creatinine ratio greater than 20:120:1. This pattern clearly indicates prerenal acute kidney injury secondary to intravascular volume depletion from aggressive diuresis. Because the patient is clinically euvolemic (clear lungs, breathing comfortably flat), the most appropriate next step in treatment evaluation is to hold the loop diuretic. This approach prevents further volume depletion and allows renal perfusion to recover, while strictly observing the patient to ensure he does not slip back into volume overload.

Adım Adım Çözüm

1
Assess the patient's clinical volume status based on symptoms and physical exam.
The patient can lie flat comfortably, has clear lungs, and has trace edema, indicating successful resolution of volume overload.
Clinical assessment is the primary driver for determining if ongoing diuresis is necessary.
2
Evaluate the new laboratory findings in the context of recent therapy.
BUN has increased to 54 mg/dL54\text{ mg/dL} and creatinine to 2.3 mg/dL2.3\text{ mg/dL} (BUN:Cr ratio >20:1> 20:1).
To identify any adverse effects of aggressive diuresis, specifically prerenal acute kidney injury.
3
Determine the safest and most appropriate intervention to address the acute kidney injury.
Hold the intravenous loop diuretic and monitor the patient.
The patient is clinically euvolemic, and pausing the diuretic allows intravascular volume to equilibrate and renal perfusion to recover without risking recurrent heart failure.

Anahtar Kavram

In patients receiving aggressive diuresis for heart failure, the development of prerenal acute kidney injury (elevated BUN and creatinine) with clinical euvolemia indicates overdiuresis, and the appropriate management is to hold the diuretic rather than administer intravenous fluids.
Tahmini Süre:1m 15s
Bu soruyu puanla